DK75687A - Hoejmolekylaere forbindelser - Google Patents
Hoejmolekylaere forbindelserInfo
- Publication number
- DK75687A DK75687A DK075687A DK75687A DK75687A DK 75687 A DK75687 A DK 75687A DK 075687 A DK075687 A DK 075687A DK 75687 A DK75687 A DK 75687A DK 75687 A DK75687 A DK 75687A
- Authority
- DK
- Denmark
- Prior art keywords
- molecular compounds
- molecular
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
- Y10S530/816—Attached to the carrier via a bridging agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3162286 | 1986-02-14 | ||
JP3162286 | 1986-02-14 | ||
JP61315089A JP2548711B2 (ja) | 1986-02-14 | 1986-12-31 | アミノ基と2官能性配位子を有する反応性高分子化合物とその利用 |
JP31508986 | 1986-12-31 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK75687D0 DK75687D0 (da) | 1987-02-13 |
DK75687A true DK75687A (da) | 1987-08-15 |
DK172629B1 DK172629B1 (da) | 1999-03-22 |
Family
ID=26370126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198700756A DK172629B1 (da) | 1986-02-14 | 1987-02-13 | Reaktive højmolekylære forbindelser med mindst én fri aminogruppe, højmolekylære forbindelser kombineret med et fysiologisk |
Country Status (7)
Country | Link |
---|---|
US (1) | US4855353A (da) |
EP (1) | EP0233619B1 (da) |
AU (1) | AU593611B2 (da) |
CA (1) | CA1266344A (da) |
DE (1) | DE3783242T2 (da) |
DK (1) | DK172629B1 (da) |
ES (1) | ES2053456T3 (da) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK172391B1 (da) * | 1986-12-30 | 1998-05-18 | Nihon Mediphysics Co Ltd | Højmolekylær forbindelse til anvendelse som ikke-radioaktiv bærer, radioaktivt mærket højmolekylær forbindelse, fremgangsmåde til fremstilling deraf og fremgangsmåde til forbedret mærkning af en asialoglycoproteinacceptor-dirigerende forbindelse |
DE3710730A1 (de) * | 1987-03-31 | 1988-10-20 | Schering Ag | Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel |
US5250702A (en) * | 1988-06-07 | 1993-10-05 | Nihon Medi-Physics Co., Ltd. | Diethylenetriamine pentaacetic acid derivatives |
US5094950A (en) * | 1988-06-07 | 1992-03-10 | Nihon Medi-Physics Co., Ltd. | Diethylenetriamine pentaacetic acid derivatives |
GR1002475B (el) * | 1988-12-05 | 1996-11-26 | Novartis Ag (Novartis Sa) (Novartis Inc.) | Μεθοδος παρασκευης πεπτιδικων παραγωγων. |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
US5028339A (en) * | 1989-01-23 | 1991-07-02 | Clark Iii William T | Polymer matrix and method for retaining reactants in a polymer matrix |
US4959148A (en) * | 1989-01-23 | 1990-09-25 | Clark Iii William T | Method and apparatus for specific affinity enhanced transport bioreactor |
US5914095A (en) * | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
US5364613A (en) * | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
WO1990013256A1 (en) * | 1989-05-04 | 1990-11-15 | Wisconsin Alumni Research Foundation | Method for localization and treatment of tumors and complexes therefor |
US5230883A (en) * | 1989-05-04 | 1993-07-27 | Wisconsin Alumni Research Foundation | Method for localization and treatment of tumors using polylysine complexes |
US5792444A (en) * | 1989-05-09 | 1998-08-11 | The General Hospital Corporation | Labeled chemotactic peptides to image focal sites of infection or inflammation |
US5650133A (en) * | 1990-01-19 | 1997-07-22 | Nycomed Salutar | Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality |
GB9320277D0 (en) * | 1993-10-01 | 1993-11-17 | Nycomed Salutar Inc | Chelants |
US5972307A (en) * | 1989-10-23 | 1999-10-26 | Nycomed Salutar, Inc. | Dichelants |
DE4115789A1 (de) * | 1991-05-10 | 1992-11-12 | Schering Ag | Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
GB9112536D0 (en) * | 1991-06-11 | 1991-07-31 | Celltech Ltd | Chemical compounds |
AU3592193A (en) * | 1992-01-14 | 1993-08-03 | Steve Pandian | Tumor imaging agent |
DE4235412A1 (de) * | 1992-10-21 | 1994-04-28 | Metallgesellschaft Ag | Verfahren zum Vergasen von brennbare Bestandteile enthaltenden Abfallstoffen |
CA2154667A1 (en) * | 1993-02-02 | 1994-08-18 | Linda M. Gustavson | Directed biodistribution of small molecules |
US5428156A (en) * | 1993-04-02 | 1995-06-27 | Associated Universities, Inc. | Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging |
US5429726A (en) * | 1993-04-30 | 1995-07-04 | The Yellow Springs Instrument Company, Inc. | Methods for reducing level of interferants in biosensor systems and solutions used in these methods |
US5605672A (en) * | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
AU675166B2 (en) * | 1993-10-22 | 1997-01-23 | Nihon Medi-Physics Co., Ltd. | Peptide having inflammation affinity and radioactive diagnostic containing the same |
US5766839A (en) * | 1994-06-17 | 1998-06-16 | Ysi Incorporated | Processes for preparing barrier layer films for use in enzyme electrodes and films made thereby |
US5958372A (en) * | 1994-06-28 | 1999-09-28 | Nycomed Imaging As | Low viscosity chelating polymers for diagnostic imaging |
US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
US5801228A (en) * | 1995-06-07 | 1998-09-01 | Nycomed Imaging As | Polymeric contrast agents for medical imaging |
US5762909A (en) * | 1995-08-31 | 1998-06-09 | General Electric Company | Tumor targeting with polymeric molecules having extended conformation |
US6107090A (en) | 1996-05-06 | 2000-08-22 | Cornell Research Foundation, Inc. | Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains |
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
US6020052A (en) * | 1996-07-30 | 2000-02-01 | Ysi Incorporated | Laminated membrane structure for polarographic measurement and methods of making said structures |
US6896874B2 (en) * | 1998-05-26 | 2005-05-24 | Wisconsin Alumni Research Foundation | MR-signal emitting coatings |
US6361759B1 (en) | 1998-05-26 | 2002-03-26 | Wisconsin Alumni Research Foundation | MR signal-emitting coatings |
MY133346A (en) | 1999-03-01 | 2007-11-30 | Biogen Inc | Kit for radiolabeling ligands with yttrium-90 |
US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
US7666414B2 (en) * | 2001-06-01 | 2010-02-23 | Cornell Research Foundation, Inc. | Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen |
IL158969A0 (en) | 2001-06-01 | 2004-05-12 | Cornell Res Foundation Inc | Modified antibodies to prostate-specific membrane antigen and uses thereof |
US7514078B2 (en) * | 2001-06-01 | 2009-04-07 | Cornell Research Foundation, Inc. | Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
AU2002305767B2 (en) | 2001-09-20 | 2008-04-10 | Cornell Research Foundation, Inc. | Methods and compositions for treating and preventing skin disorders using binding agents specific for PSMA |
US20040024317A1 (en) * | 2002-07-31 | 2004-02-05 | Uzgiris Egidijus E. | Method for assessing capillary permeability |
US20040136998A1 (en) * | 2002-10-30 | 2004-07-15 | Bander Neil H. | Methods and compositions for treating or preventing insulin-related disorders using binding agents specific for prostate specific membrane antigen |
AU2003293556A1 (en) | 2003-01-10 | 2004-08-10 | Millennium Pharmaceuticals, Inc. | Methods of diagnosing and treating cancer |
US20040253292A1 (en) * | 2003-04-23 | 2004-12-16 | Wisconsin Alumni Research Foundation | MR-signal emitting coatings |
WO2005070456A2 (en) * | 2004-01-09 | 2005-08-04 | Millennium Pharmaceuticals, Inc. | Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies |
WO2005094882A1 (en) * | 2004-03-03 | 2005-10-13 | Millennium Pharmaceuticals, Inc. | Modified antibodies to prostate-specific membrane antigen and uses thereof |
US8457712B2 (en) * | 2005-12-30 | 2013-06-04 | Wisconsin Alumni Research Foundation | Multi-mode medical device system and methods of manufacturing and using same |
US20070156042A1 (en) * | 2005-12-30 | 2007-07-05 | Orhan Unal | Medical device system and method for tracking and visualizing a medical device system under MR guidance |
WO2007084693A2 (en) * | 2006-01-20 | 2007-07-26 | Welson Pharmaceuticals, Inc. | Immunoconjugates with improved efficacy for the treatment of diseases |
US8532742B2 (en) * | 2006-11-15 | 2013-09-10 | Wisconsin Alumni Research Foundation | System and method for simultaneous 3DPR device tracking and imaging under MR-guidance for therapeutic endovascular interventions |
DE102007002726A1 (de) | 2007-01-18 | 2008-07-31 | Bayer Schering Pharma Aktiengesellschaft | Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
US20080183070A1 (en) * | 2007-01-29 | 2008-07-31 | Wisconsin Alumni Research Foundation | Multi-mode medical device system with thermal ablation capability and methods of using same |
US20080208039A1 (en) * | 2007-02-28 | 2008-08-28 | Wisconsin Alumni Research Foundation | System and method of performing therapeutic endovascular interventions |
GB201417067D0 (en) | 2014-09-26 | 2014-11-12 | South African Nuclear Energy | Radiopharmaceutical conjugate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56125317A (en) * | 1980-03-08 | 1981-10-01 | Nippon Mejifuijitsukusu Kk | Stable radioactive diagnosticum with radioactive metallic mark |
JPS5850656B2 (ja) * | 1980-04-10 | 1983-11-11 | 財団法人生産開発科学研究所 | 両性ポリアミド樹脂 |
US4511550A (en) * | 1982-09-07 | 1985-04-16 | Nihon Medi-Physics Co., Ltd. | 1-(p-Substituted or unsubstituted aminoalkyl)phenylpropane-1,2-dione bis(thiosemicarbazone) derivatives, and their production and use |
JPS59215321A (ja) * | 1983-05-23 | 1984-12-05 | Sumitomo Chem Co Ltd | 二官能性配位子化合物を結合した反応性高分子 |
US4707352A (en) * | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group |
-
1987
- 1987-02-13 AU AU68782/87A patent/AU593611B2/en not_active Ceased
- 1987-02-13 DK DK198700756A patent/DK172629B1/da not_active IP Right Cessation
- 1987-02-13 CA CA000529700A patent/CA1266344A/en not_active Expired - Fee Related
- 1987-02-14 DE DE8787102123T patent/DE3783242T2/de not_active Expired - Fee Related
- 1987-02-14 EP EP87102123A patent/EP0233619B1/en not_active Expired - Lifetime
- 1987-02-14 ES ES87102123T patent/ES2053456T3/es not_active Expired - Lifetime
- 1987-02-17 US US07/015,633 patent/US4855353A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA1266344A (en) | 1990-02-27 |
US4855353A (en) | 1989-08-08 |
EP0233619B1 (en) | 1992-12-30 |
DK172629B1 (da) | 1999-03-22 |
AU6878287A (en) | 1987-08-20 |
DE3783242D1 (de) | 1993-02-11 |
DE3783242T2 (de) | 1993-04-29 |
AU593611B2 (en) | 1990-02-15 |
ES2053456T3 (es) | 1994-08-01 |
DK75687D0 (da) | 1987-02-13 |
EP0233619A1 (en) | 1987-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK75687D0 (da) | Hoejmolekylaere forbindelser | |
DK594687A (da) | Pyrrolidinylthioforbindelser | |
DK126388A (da) | Referenceelektrode | |
DK270387D0 (da) | Traefraeser | |
FI880339A (fi) | Leikkitoimintakeskus | |
DK492587D0 (da) | Substituerede indolquinoxaliner | |
PT84187A (pt) | Novel compounds | |
DK519787D0 (da) | Stroemledeflade | |
DK290487A (da) | Substituerede 3-amino-2-benzoylcyklohex-2-enoner | |
DK249087A (da) | Alfa-halogenpyruvatoxim | |
IT8753315V0 (it) | Scendibagno | |
FR2599154B1 (fr) | Altimetre-radar | |
DK329687D0 (da) | Antitrypsinderivat | |
DK178786A (da) | Vaeskecontainer | |
DK182587A (da) | 3-diphenyl-substituerede octahydroindolizinforbindelser | |
RO93675A2 (ro) | Transportor basculant pentru busteni | |
ES293781Y (es) | Pachero-hornillo mejorado | |
ES1001379Y (es) | Abrazadera-soporte mejorada | |
ES1001310Y (es) | Falleba mejorada | |
ES1000052Y (es) | Monocontacto mejorado | |
ES1000048Y (es) | Termocontacto mejorado | |
BR8600832A (pt) | Divisoria aperfeicoada | |
FI923615A0 (fi) | Substituoituja N3-tioasyylisemikarbatsideja | |
BR8604705A (pt) | Vibro-massageador | |
DK220186D0 (da) | Baadtelt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |